# Xeomin® and Gait Related Mobility After Stroke

> **NCT04908423** · PHASE4 · RECRUITING · sponsor: **Wake Forest University Health Sciences** · enrollment: 20 (estimated)

## Conditions studied

- Stroke

## Interventions

- **DRUG:** Xeomin®

## Key facts

- **NCT ID:** NCT04908423
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-10-19
- **Primary completion:** 2027-04
- **Final completion:** 2027-04
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-11-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04908423

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04908423, "Xeomin® and Gait Related Mobility After Stroke". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT04908423. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*